Company Announcements Revenue for Takara Bio’s Genetic Engineering Research unit declined 0.3% for the fiscal year ending March 31 to ¥16,689 million ($179.7 million) to make up 87% of Takara Bio sales. Operating income rose 8.7% to ¥4,151 million ($44.7 million) (see IBO 9/30/10). Sales of research reagents declined, partly due to the yen’s appreciation, […]
Cambridge, MA 10/14/10; Washington, DC 10/15/10—Helicos BioSciences has appointed Dr. Ivan Trifunovich as president and CEO. He served as a senior consultant to the Board and was elected executive chairman last month. Previously, he served as senior vice president of molecular diagnostics firm Third Wave Technologies. Helicos BioSciences also announced the launch of a technology-licensing […]
Orange County, CA 9/7/10—Beckman Coulter Chairman, President and CEO Scott Garrett has resigned, effective September 6. He will continue as a full-time nonexecutive employee through January 15, 2011. The Board has named J. Robert Hurley interim president and CEO. He has served as senior vice president, Human Resources, and chairman of Beckman Coulter Japan. He […]
Company Announcements Merck Millipore updated its 2010 nonGAAP guidance for Millipore as a stand-alone company, estimating that revenue will increase 8.8% to $1,800 million and operating income will grow 18.8% to $405 million. In June, the University of California San Diego, the Salk Institute for Biological Studies and Life Technologies initiated stem cell research on […]
Company Announcements Life Technologies announced the closure of manufacturing sites in Camarillo, California, and Bromborough, UK. Operations will be consolidated at the Frederick, Maryland, and Warrington, UK, facilities. Life Technologies formed the GIBCO Cell Therapy Systems product portfolio in June, which offers products to support cell therapy applications, including regenerative medicine. Biotage A/S named Andres […]
Company Announcements Biotage AB announced a distribution partnership with John Morris Scientific for Australia and New Zealand. In April, Biotage announced long-term financial goals that can be achieved by 2012: organic growth of at least 10%, an increase in gross margin by 1–2 percentage points per year with a goal of achieving a gross margin […]
Company Announcements Anton Paar opened its 13th subsidiary in Zofingen, Switzerland, in January. In 2009, sales for Corning’s Life Sciences segment grew 12.3% to $366 million (see IBO 3/31/10) to make up 7% of company sales. The increase was due to the acquisition of Axygen (see IBO 9/30/09), but existing life science product volumes declined. […]
Following the 2008 recession and heightened scrutiny over executive rewards, there is little surprise that total executive compensation for the executives in IBO’s annual executive compensation tables declined last year. In fiscal 2009, total average compensation for the 57 executives at 42 analytical instrument and laboratory product companies in IBO’s three Stock Indexes (see IBO […]
Fremont, CA 4/1/10—Bruker has created a Chemical Analysis Division within its Bruker Daltonics subsidiary. The Division will include the ICP-MS, lab GC and triple quadrupole GC-MS product lines that Bruker plans to acquire from Agilent (see IBO 3/15/10). Collin D’Silva, a Bruker board member until this month and former CEO of Transgenomic, will manage the […]
Company Announcements Illumina Board member Jack Goldstein will not stand for re-election in May. Thermo Fisher Scientific completed a 35,000-square-foot addition to its Pierce facility in Rockford, Illinois. In February, Thermo Fisher Scientific opened an additional facility in Cheshire, UK, adding 60 new jobs. The facility serves as a Center of Excellence for its Anatomical […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
